[Case-control study evaluating the incidence of hyperhomocysteinemia in cancer patients in an internal medicine department]. / Etude cas témoin évaluant l'incidence de l'hyperhomocystéinémie chez des patients porteurs de néoplasie dans un service de médecine interne.
Rev Med Interne
; 28(8): 520-5, 2007 Aug.
Article
em Fr
| MEDLINE
| ID: mdl-17537549
ABSTRACT
PURPOSE:
Cancer is a cause of venous thromboembolism. However, the physiopathology remains unknown. Hyperhomocysteinemia could be a promoting factor.METHOD:
We built a case-control study of 65 patients followed for 2 years to compare levels of homocystéinémie in cancer bearing patients with that in matched cancer free control patients.RESULTS:
Fifty per cent of cancer bearing patients had significantly increased blood serum levels of homocystéine (P=0.006). This increase did not correlate with any deficiency in blood serum levels of folate or vitamin B12.CONCLUSION:
High levels of homocystéinémie could be linked to tumor proliferation.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Hiper-Homocisteinemia
/
Homocisteína
/
Neoplasias
Tipo de estudo:
Incidence_studies
/
Observational_studies
/
Prognostic_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Fr
Ano de publicação:
2007
Tipo de documento:
Article